18-MC is a proprietary, non-hallucinogenic molecule, based on the psychedelic ibogaine. In extensive nonclinical testing, 18-MC has shown promise …
Join Claudio Naranjo at the Global Ibogaine Conference 2016
Claudio Naranjo will give a keynote about Ibogaine, his early day experiments and ibogaine’s therapeutic potential, at the Global Ibogaine Conference, Tepoztlan, Mexico, March 14-16 of 2016. Don’t miss this event! www.ibogaineconference.org
source
Claudio Naranjo: The Early Days’ Ibogaine Experiments
Interview with the Chilean Psychiatrist Claudio Naranjo about his clinical experiments in the 60s with Ibogaine; his findings, observations on therapeutic potential and phenomenology, etc.
Interview conducted in Mexico, April 2014
source